Millennium Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-146,750
| Closed | -$704K | – | 5756 |
|
|
2021
Q1 | $704K | Buy |
+146,750
| New | +$704K | ﹤0.01% | 3456 |
|
|
2019
Q3 | – | Sell |
-325,417
| Closed | -$2.02M | – | 3931 |
|
|
2019
Q2 | $2.02M | Sell |
325,417
-692,566
| -68% | -$4.29M | ﹤0.01% | 2016 |
|
|
2019
Q1 | $7.24M | Buy |
1,017,983
+538,084
| +112% | +$3.83M | 0.01% | 1289 |
|
|
2018
Q4 | $4.1M | Buy |
479,899
+229,404
| +92% | +$1.96M | 0.01% | 1535 |
|
|
2018
Q3 | $5.02M | Sell |
250,495
-91,685
| -27% | -$1.84M | 0.01% | 1583 |
|
|
2018
Q2 | $8.84M | Buy |
342,180
+260,360
| +318% | +$6.73M | 0.01% | 1274 |
|
|
2018
Q1 | $1.96M | Sell |
81,820
-575,263
| -88% | -$13.7M | ﹤0.01% | 2167 |
|
|
2017
Q4 | $22.3M | Sell |
657,083
-603,496
| -48% | -$20.5M | 0.03% | 814 |
|
|
2017
Q3 | $26.7M | Buy |
1,260,579
+923,203
| +274% | +$19.5M | 0.04% | 608 |
|
|
2017
Q2 | $5.9M | Sell |
337,376
-105,691
| -24% | -$1.85M | 0.01% | 1284 |
|
|
2017
Q1 | $7.75M | Sell |
443,067
-96,782
| -18% | -$1.69M | 0.01% | 1087 |
|
|
2016
Q4 | $9.12M | Sell |
539,849
-177,526
| -25% | -$3M | 0.02% | 932 |
|
|
2016
Q3 | $11.8M | Buy |
717,375
+160,806
| +29% | +$2.64M | 0.02% | 790 |
|
|
2016
Q2 | $8.43M | Buy |
556,569
+542,577
| +3,878% | +$8.21M | 0.02% | 904 |
|
|
2016
Q1 | $202K | Sell |
13,992
-359,248
| -96% | -$5.19M | ﹤0.01% | 2714 |
|
|
2015
Q4 | $10.6M | Buy |
373,240
+319,689
| +597% | +$9.05M | 0.02% | 863 |
|
|
2015
Q3 | $896K | Buy |
53,551
+35,883
| +203% | +$600K | ﹤0.01% | 2160 |
|
|
2015
Q2 | $463K | Sell |
17,668
-27,087
| -61% | -$710K | ﹤0.01% | 2473 |
|
|
2015
Q1 | $783K | Buy |
44,755
+32,500
| +265% | +$569K | ﹤0.01% | 2256 |
|
|
2014
Q4 | $213K | Buy |
+12,255
| New | +$213K | ﹤0.01% | 2961 |
|